Latest News

STAT Plus: Lawmakers’ coronavirus response means delays for drug pricing legislation

WASHINGTON — Before the coronavirus pandemic became Congress’ sole focus, late May was widely viewed as a final 2020 deadline for lawmakers to take action on key health policy issues, including legislation to lower the price of prescription drugs.

But with the Covid-19 crisis dominating every aspect of American politics, such legislation will have to wait. A recent $2 trillion relief package that lawmakers passed on Friday could mean drug pricing advocates might be waiting a long while — likely until November, weeks after Election Day.

Continue to STAT Plus to read the full story…

Source link

Related posts

Opinion: Medicare’s new primary care payment rule is good news for patients


Samenvatting: Nieuwe studie onderzoekt het nut van thuismonitoring met behulp van Masimo SET® Pulse Oximetry bij het screenen van kinderen met Down-syndroom voor het risico van obstructieve slaapapneu Voorafgaand aan diagnostische multichannel slaaponderzoeken


CFTR inhibition: The key to treating bile acid diarrhea?


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy